Key result
In patients with acute heart failure, ischemic cardiomyopathy was associated with higher troponin and BNP levels and greater cardiovascular mortality compared to idiopathic dilated cardiomyopathy.
Why the study?
Do biomarker levels of troponin and natriuretic peptides differ between ischemic and idiopathic dilated etiologies of severe heart failure?
Cohort (n=40)
Do biomarker levels of troponin and natriuretic peptides differ between ischemic and idiopathic dilated etiologies of severe heart failure?
Patients with acutely decompensated heart failure due to ischemic cardiomyopathy have significantly higher levels of troponin and BNP, and higher mortality, compared to those with idiopathic dilated cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May inform etiology-specific risk stratification in acute HF; leaves open whether ischemic cardiomyopathy warrants distinct management.
BACKGROUND: Ischemic (ISCM) and idiopathic dilated (IDCM) cardiomyopathies have different responses to therapy and outcomes. Both may demonstrate elevations in troponin and B-type natriuretic peptides, but biomarker levels have not been reported to differ as a function of the etiology of heart failure (HF). Accordingly, we compared these biomarkers in patients with chronic HF. HYPOTHESIS: Biomarker levels of troponin T, troponin I, B-type natriuretic peptide (BNP), and N-terminal prohormone brain natriuretic peptide (NT-proBNP) are quantitatively different between ischemic and idiopathic dilated etiologies of chronic HF. METHODS: Forty patients (27 male, 68 +/- 2 years; LVEF 25 +/- 1%; NYHA Class III-IV) admitted to hospital for acute HF were studied. Biomarkers were drawn at admission prior to treatment intervention. RESULTS: Of the 40 patients, 27 had ISCM and 13 IDCM. Baseline clinical characteristics were similar with the exception of GFR. cTnT, cTnI, and BNP levels were higher in ISCM patients (cTnT: 0.373 +/- 0.145 vs. 0.064 +/- 0.016 ng/mL, p < 0.05; cTnI: 2.02 +/- 0.76 vs. 0.21 +/- 0.11 ng/mL, p < 0.05; BNP: 776 +/- 91 vs. 532 +/- 85 pg/mL, p < 0.05). Cardiovascular mortality during follow up (10 +/- 1 months) was 48% in patients with ISCM and 23% with IDCM (p < 0.05). CONCLUSIONS: Patients with acutely decompensated chronic HF have elevations in troponin and BNP. These elevations, as well as mortality are significantly higher in patients with ISCM compared to IDCM. The differential levels in biomarkers may be due to differences in disease pathogenesis, and fit with the adverse prognosis in these patients.
No takes yet. Share an insight, caveat, or question.
Miller et al. (2007) conducted a cohort in Acute heart failure (n=40). Ischemic cardiomyopathy vs. Idiopathic dilated cardiomyopathy was evaluated on Cardiovascular mortality (p=<0.05). In patients with acute heart failure, ischemic cardiomyopathy was associated with higher troponin and BNP levels and greater cardiovascular mortality compared to idiopathic dilated cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: